Intraperitoneal chemotherapy for ovarian cancer

scientific article published on 01 July 2016

Intraperitoneal chemotherapy for ovarian cancer is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1016/J.YGYNO.2016.06.011
P698PubMed publication ID27328898

P2093author name stringJoan L Walker
P2860cites workIntraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion ratesQ36995650
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerQ44461877
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.Q53263238
P433issue1
P921main subjectovarian cancerQ172341
P304page(s)1-2
P577publication date2016-07-01
P1433published inGynecologic OncologyQ5625182
P1476titleIntraperitoneal chemotherapy for ovarian cancer
P478volume142

Reverse relations

cites work (P2860)
Q57481603Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer
Q91592033Phase III trials in ovarian cancer: The evolving landscape of front line therapy
Q91856102The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms

Search more.